BL
Blue Lake Biotechnology is developing a human vaccine that employs a novel viral vector to generate a strong immune response against infectious diseases. This technology aims to improve vaccine efficacy and increase accessibility in response to the global demand for effective immunization solutions.
Updated 4 months ago
Funding
$18.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Blue Lake Biotechnology is developing a human vaccine that employs a novel viral vector to generate a strong immune response against infectious diseases. This technology aims to improve vaccine efficacy and increase accessibility in response to the global demand for effective immunization solutions.